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and the EQ-5D Index (EQ-I) (1.13) compared with the
remaining antipsychotic drugs (0.58-0.75 for the VAS
and 0.78-0.96 for the EQ-I). The olanzapine-treated
group had the highest proportion of patients with an im-
provement, particularly in the daily activities and mood
domains, and the lowest proportion of patients who
worsened after 6 months of treatment.
CONCLUSION: Treatment with antipsychotic drugs, es-
pecially olanzapine, improves the HRQL of patients with
schizophrenia. The study also indicates that the EQ-5D is
useful and sensitive tool for detecting changes in the
health of patients with schizophrenia.
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OBJECTIVES: To improve the evaluative-scale character-
istics of the WHQ. Comparative clinical trials require eval-
uative scales that are sensitive and responsive as well as
valid and reliable. The Women’s Health Questionnaire
(WHQ), a 36-item, 4-point Likert self-administered rating
scale, assesses subjective reports of emotional and physical
well-being in mid-aged women using nine physical, emo-
tional, and symptom-specific scales. We assessed the
WHQ evaluative scale properties using both true score and
Rasch measurement models to determine whether the
scoring techniques proposed by the scale developer opti-
mized the evaluative properties.
METHODS: We analyzed WHQ baseline and six-week
change score data from 651 mid-aged women treated
with HRT in two US clinical trials. The Multitrait/Multi-
item Analysis Program—Revised provided true score psy-
chometric information. The BIGSTEPS program pro-
duced the Rasch analysis.
RESULTS: The original nine-factor structure was not sup-
ported by confirmatory factor analysis. Rasch analysis
identified scale-level category response problems for sev-
eral scales in the revised six-factor structure. The problem-
atic scales failed to detect differences between “known
groups” formed by clinical criteria for menopausal symp-
toms, and were not responsive to change within groups
that changed significantly on clinical criteria. Revised scale
scoring based on Rasch conversion to standardized logits
resulted in improved sensitivity and responsiveness.
CONCLUSIONS: Rasch models provide important psy-
chometric information for scale development and revi-
sion. They resolve interval data assumptions, are more
sensitive to information contained in the tails of the re-
sponse distributions, and yield useful response category
analyses that guide scaling decisions independent of the
sample characteristics. Based on the Rasch analysis, we
made scoring and interpretation changes to the WHQ
that increased its sensitivity and responsiveness.
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OBJECTIVES: Measurements of the patient health status
should be simple and concise in clinical practice. The
Asthma Bother Profile (ABP), which consists of 23 items,
has been developed to assess how much asthma bothers pa-
tients. The Airway Questionnaire 20 (AQ20) is a simple in-
strument which consists of 20 items regarding the health
status of asthma and COPD patients. The purpose of this
study was to investigate how the ABP and AQ20 evaluate
the health status of patients with asthma, and to examine
the relationships between these two measures and clinical
parameters, generic and asthma-specific instruments.
METHODS: A total of 193 patients with chronic asthma
(age: 48  8 yr, 95 males) completed a pulmonary function
testing, a measurement of airway hyperresponsiveness, the
dyspnea rating (MRC; Medical Research Council dyspnea
scale), and assessments of the anxiety and depression
(HADS; Hospital Anxiety and Depression Scale), and as-
sessments of their health status. The health status was as-
sessed using the ABP, AQ20, SF-36, Living with Asthma
Questionnaire (LWAQ) and the Asthma Quality of Life
Questionnaire (AQLQ). The Japanese version of the ABP
included only 15 items out of the original 23 items due to
cultural differences.
RESULTS: The score distributions on the ABP and AQ20
were skewed towards the mild end of the scale (median
score [interquartile range]: 2 [1–4] and 13 [6–22], respec-
tively). Moderate correlations were noted between the
Anxiety on the HADS and the ABP and AQ20 scores
(Spearman’s rank correlation coefficient [Rs]  0.44 and
0.62 respectively). The ABP had a strong correlation with
the LWAQ (Rs  0.81), and its strongest correlation
with the General Health (Rs  0.64) among the 8 sub-
scales on the SF-36. The AQ20 had a moderate correlation
with the LWAQ (Rs  0.61). The FEV1, peak expiratory
flow rates, degree of airway hyperresponsiveness and treat-
ment steps of asthma showed mild correlations with the
ABP and AQ20 (Rs  0.20  0.26).
CONCLUSIONS: The ABP and AQ20 were short and
simple to complete, and both measures could easily be used
in clinical practice. The ABP can evaluate patients more
specifically with respect to the distress and bother induced
by asthma than the AQ20.
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OBJECTIVE: To estimate prevalence of Urinary Inconti-
nence (UI) in the Portuguese population. To determine the
costs of treatment (including incontinent pad usage) with
Tolterodine for patients suffering from chronic UI.
METHODS: Data from the National Health Survey per-
formed in 1995–96, involving a representative sample of
49718 people across mainland Portugal, was analyzed to
determine age, sex-specific and age-standardized preva-
lence rates of UI. The average consumption of pads by in-
continent patients was estimated from the information pro-
vided by the Centro Regional de Saúde from Madeira
Island, a region where pads are reimbursed.
RESULTS: The global prevalence of urinary incontinence
in Portugal was of 4,3%, being 2,6% in males and 5,8% in
females. Age and sex adjusted prevalence rates were of
1,9% in males while 4,4% in females. Age and sex specific
prevalence rates increase with age from 15 years onwards
in both sexes, being higher in females across all age groups.
Above 65 years of age 10% of men and 12% of women
suffer from urinary incontinence. Of these, 68,8% are
likely to suffer from chronic urinary incontinence. This is
the estimated burden of the disease in the general Portu-
guese population. Urinary incontinent chronic patients use
on average 4 pads per 24 hours, normally using 3 pads dur-
ing the day and 1 pad at night. Comparing the average pad
costs per day with using Tolterodine, the difference is re-
markable (648$00 PTE versus 334$60 PTE). The eco-
nomic impact of such use would reduce the health expendi-
ture in UI patients significantly.
CONCLUSION: The prevalence of UI in Portugal is
within the limits of what is mentioned in other community-
based studies. The average daily costs of treatment with
Tolterodine are lower when compared with pad usage.
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OBJECTIVES: To apply bootstrap techniques to derive
confidence intervals (CIs) for cost differences between two
anaesthetic regimes, and to compare with standard para-
metric methods for deriving CIs.
METHODS: In a cardiac surgery clinical trial, patients were
randomized to one of two anaesthetic regimes, either propo-
fol or midazolam, for the induction and maintenance of an-
esthesia, and sedation post-surgery in ICU. A cost compari-
son of these two regimes was published in 1996, with all
drug usage and ICU nursing time costs. Parametric methods
were used to construct 95% CIs for the difference between
propofol and midazolam. Untransformed parametric analy-
sis of cost data often fails because of distributional skew-
ness. Therefore, log-transformed analysis was undertaken to
overcome the skewness problem. More recently, log-trans-
formation has become a discredited strategy because health-
care decision-makers focus on total budgets—for instance,
the total annual budget available to provide surgery at a
particular centre. The only estimator directly linked to this
total cost is the arithmetic mean—therefore any analysis
based upon geometric means, arising from log-transforma-
tion, is inappropriate. Other authors have therefore recom-
mended bootstrap techniques to produce CIs for cost differ-
ences on an untransformed scale. This approach is not
invalidated by distributional skewness.
RESULTS: With 37 propofol and 33 midazolam patients,
a comparison of drug plus nursing costs showed an advan-
tage per subject for propofol of £43.23 (95% CI: £3.21
to £89.67). An untransformed two-sample t-test proved in-
appropriate, because the necessary distributional assump-
tions were not satisfied. Bootstrap CIs for the cost differ-
ence were then constructed using four different bootstrap
techniques. All bootstrap CIs showed a striking similarity
to the untransformed estimates above, demonstrating the
robustness of the t-test and conventional parametric meth-
ods, despite distributional skewness.
CONCLUSIONS: Both untransformed and bootstrap esti-
mates should be presented—hopefully, the two methods will
be in agreement and provide mutually supportive evidence.
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OBJECTIVE: To develop and validate a brief survey of mi-
graine-related quality of life issues. Unlike other instru-
ments that define the impact of acute treatment, the Qual-
ity of Life with Migraine (QOLWM) questionnaire was
designed to assess the chronic impact of migraine.
METHODS: Major issues related to living with chronic,
frequent migraine headaches were condensed into seven
topics. Each item was structured as a question about fre-
quency and a question about bothersomeness. Item scores
were the products of frequency and bothersomeness. The
total score was the sum of the seven item scores. People
with migraine who voluntarily responded to a headache
survey also completed the QOLWM and the Headache
Disability Index (HDI).
RESULTS: The QOLWM was completed in full by 994
adults (81% women) with mean total score 77.98  40.49
(range 7–175). There were no floor or ceiling effects. Inter-
nal consistency reliability (Cronbach’s alpha) of 0.93 was
excellent, with item-scale correlations of 0.59–0.83. The
eigenvalue of the single factor was 4.78, with item loadings
